Anti-hyperglycaemic and hypolipidemic effects of Ocimum basilicum aqueous extract in diabetic rats

American Journal of Pharmacology and Toxicology

Volumn 2, Issue 3, 2007, Pages 123-129

  Zeggwagh, Naoufel Ali ^a   Sulpice, Thierry ^b   Eddouks, Mohamed ^a,c  

^a MOULAY ISMAIL UNIVERSITY   (Morocco)

^b Physiogenex   (France)

^c NONE   (Morocco)

Author keywords

Anti hyperglycaemic; Aqueous extract; Ocimum basilicum; Oral administration

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; OCIMUM BASILICUM EXTRACT; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; NONHUMAN; OUTCOME ASSESSMENT; RAT; SOLVENT EXTRACTION; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

OCIMUM BASILICUM; RATTUS;

EID: 38749106579     PISSN: 15574962     EISSN: 15574970     Source Type: Journal    
DOI: 10.3844/ajptsp.2007.123.129     Document Type: Article

References (37)

1. Zimmet, P., 2000. Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted? J. Intern. Med., 247 (3): 301-310.
2. Amos, A.F., D.J. McCarty and P. Zimmet, 1997. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet. Med., 14 (3): S1-85.
3. Wagman, A.S and J.M. Nuss, 2001. Current therapies and emerging targets for the treatment of diabetes. Curr. Pharm. Des., 7 (6): 417-450.
4. Goldberg, I.J., 2001. Clinical review 124: Diabetic dyslipidemia: causes and consequences. J. Clin. Endocrinol. Metab., 86 (3): 965-971.
5. Stern, M.P., B.D. Mitchell, S.M. Haffner and H.P. Hazuda, 1992. Does glycemic control of type II diabetes suffice to control diabetic dyslipidemia? A community perspective. Diabetes Care, 15 (5): 638-644.
6. Marles, R.J. and N.R. Farnsworth, 1995. Antidiabetic plants and their active constituents. Phytomedicine, 2 (2): 137-189.
7. Thompson Coon, J. S and Ernst, E. 2003. Herbs for serum cholesterol reduction: a systematic view. J. Fam. Pract., 52 (6): 468-478.
8. Hooft, R., 2003. Drug discovery and development for metabolic diseases. Drug. Discov. Today., 8 (23): 1064-1066.
9. Eddouks, M., M. Maghrani, A. Lemhadri, M.L. Ouahidi and H. Jouad, 2002. Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet). J. Ethnopharmacol., 82 (2-3): 97-103.
10. Pederson, R.A., S. Ramanadham, A.M. Buchan, J.H. McNeill, 1989. Long-term effects of vanadyl treatment on streptozocin-induced diabetes in rats. Diabetes, 38 (11): 1390-1395.
11. Gupta, D., J. Raju, J. Prakash, N.Z. Baquer, 1999. Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: effect of insulin and vanadate. Diabetes. Res. Clin. Pract., 46 (1): 1-7.
12. Harrigan, R.A., M.S. Nathan, P. Beattie, 2001. Oral agent for the treatment of type 2 diabetes mellitus: pharamcology toxicology and treatment. Annals of Emergency Medecine, 38 (1): 68-78.
13. Oubre, A.Y., T.J. Carlson, S.R. King, G.M. Reaven, 1997. From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM, Diabetologia, 40 (5): 614-617.
14. Bhandari U., R. kanojia, K.K. Pillai, 2005. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats, J. Ethnopharmacol., 97 (2): 227-230.
15. Eddouks, M., A. Lemhadri, J.B. Michel, 2005. Hypolipidemic activity of aqueous extract of Capparis spinosa L. in normal and diabetic rats. J. Ethnopharmacol., 98 (3): 345-350.
16. Jouad, H., M. Eddouks, M.A. Lacaille-Dubois, B. Lyoussi, 2000. Hypoglycaemic effect of spergularia purpurea in normal and streptozotocin-induced diabetic rats. J. Ethnopharmacol., 71 (1-2): 169-177.
17. Jouad, H., A. Lemhadri, M. Maghrani, N.A. Zeggwagh, M. Eddouks, 2003. Cholesterol-lowering activity of the aqueous extract of Spergularia purpurea in normal and recent-onset diabetic rats. J. Ethnopharmacol., 87 (1): 43-49.
18. Kameswara Rao, B., M.M. Kesavulu, R. Giri, C. Appa Rao, 1999. Antidiabetic and hypolipidemic effects of Momordica cymbalaria Hook. fruit powder in alloxan-diabetic rats. J. Ethnopharmacol., 67 (1): 103-109.
19. Wannissorn, B., S. Jarikasem, T. Siriwangchai, S. Thubthimthed, 2005. Antibacterial properties of essential oils from Thai medicinal plants. Fitoterapia, 76 (2): 233-236.
20. Pavela, R., 2004. Insecticidal activity of certain medicinal plants. Fitoterapia, 75 (7-8): 745-749.
21. Dasgupta, T., A.R. Rao, and P.K. Yadava, 2004. Chemomodulatory efficacy of basil leaf (Ocimum basilicum) on drug metabolizing and antioxidant enzymes, and on carcinogen-induced skin and forestomach papillomagenesis. Phytomedicine, 11 (2-3): 139-151.
22. Vats, V., J.K. Grover, S. and S. Rathi, 2002. Evaluation of anti-hyperglycemic and hypoglycemic effect of Trigonella foenum-graecum Linn, Ocimum sanctum Linn and Pterocarpus marsupium Linn in normal and alloxanized diabetic rats. J. Ethnopharmacol., 79 (1): 95-100.
23. Marti, L., A. Abella, C. Carpene, M. Palacin, X. Testar, A. Zorzano, 2001. Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats. Diabetes, 50 (9): 2061-2068.
24. Junod, A., A.E. Lambert, W. Stauffacher, A.E. Renold, 1969. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J. Clin. Invest., 48 (11): 2129-2139.
25. Mathe, D. 1995. Dyslipidemia and diabetes: animal models. Diabete. Metab., 21 (2): 106-111.
26. Gerich, J.E., 1988. Glucose counterregulation and its impact on diabetes mellitus. Diabetes, 37 (12): 1608-1617.
27. Blondel, O. and B. Portha, 1989. Early appearance of in vivo insulin resistance in adult streptozotocin-injected rats. Diabete. Metab., 15 (6): 382-387.
28. Yki-Jarvinen, H., 1990. Acute and chronic effects of hyperglycaemia on glucose metabolism. Diabetologia, 33 (10): 579-585.
29. Eddouks, M., H. Jouad, M. Maghrani, A. Lemhadri, and R. Burcelin, 2003. Inhibition of endogenous glucose production accounts for hypoglycemic effect of Spergularia purpurea in streptozotocin mice. Phytomedicine, 10 (6-7): 594-599.
30. Eddouks, M and M. Maghrani, 2004. Phlorizin-like effect of Fraxinus excelsior in normal and diabetic rats. J. Ethnopharmacol., 94 (1): 149-154.
31. Hu, X.J., Y. Oshida, M. Xu, G. Bajotto and Y. Sato, 2003. Effect of Gosha-jinki-gan (Chinese herbal medicine: Niu-Che-Sen-Qi-Wan) on insulin resistance in streptozotocin-induced diabetic rats. Diabetes. Res. Clin. Pract., 59 (2): 103-111.
32. Welihinda, J and E.H. Karunanayake, 1986. Extra-pancreatic effects of Momordica charantia in rats. J. Ethnopharmacol., 17 (3): 247-255.
33. Nabel, E.G., 2003. Cardiovascular disease. N. Engl. J. Med., 349 (1): 60-72.
34. Garg, A., 1994. Management of dyslipidemia in IDDM patients. Diabetes Care, 17 (3): 224-234.
35. Zhang, Z., W.K. Ho, Y. Huang, A.E. James, L.W. Lam and Z.Y. Chen, 2002. Hawthorn fruit is hypolipidemic in rabbits fed a high cholesterol diet. J. Nutr., 132 (1): 5-10.
36. Kim, S.H., K.S. Park, 2003. Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacol. Res., 48 (5): 511-513.
37. Markku, L., 1995. Epidemiology of diabetes dyslipidemia. Diabetes Reviews, 3 (3): 408-422.